cocaine has been researched along with buprenorphine in 133 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (5.26) | 18.7374 |
1990's | 64 (48.12) | 18.2507 |
2000's | 18 (13.53) | 29.6817 |
2010's | 27 (20.30) | 24.3611 |
2020's | 17 (12.78) | 2.80 |
Authors | Studies |
---|---|
Masukawa, Y; Misawa, M; Nagase, H; Shiozaki, Y; Suzuki, T | 1 |
Ellingboe, J; Mello, NK; Mendelson, JH; Teoh, SK | 1 |
Brooke, D; Fudala, PJ; Johnson, RE | 1 |
Doty, P; Dykstra, LA; Johnson, AB; Picker, MJ | 1 |
Mello, NK; Mendelson, JH | 2 |
Cone, EJ; Drieze, J; Kamien, JB; Lukas, SE; Mello, NK; Mendelson, JH | 1 |
Buzalsky, S; Carmona, GN; Carroll, ME; Larson, C; May, SA | 1 |
Skjoldager, P; Winger, G; Woods, JH | 1 |
Carroll, ME; Lac, ST | 1 |
Kosten, TR; Rosen, MI; Schottenfeld, R; Ziedonis, D | 1 |
Goldberg, SR; Grayson, NA; Jaffe, JH; Johnson, RE; Katz, JL; Rice, KC; Witkin, JM | 1 |
Grayson, NA; Rice, KC; Rothman, RB; Xu, H | 1 |
Bansinath, M; Goldfrank, LR; Shukla, VK; Turndorf, H | 1 |
Mello, NK | 1 |
Dooley-Coufos, K; Kuehnle, J; Mello, NK; Mendelson, JH; Sintavanarong, P; Teoh, SK | 1 |
Fudala, PJ; Jaffe, JH; Johnson, RE | 1 |
Kamien, JB; Lukas, SE; Mello, NK; Mendelson, JH | 2 |
Stimmel, B | 1 |
Kosten, TA; Marby, DW; Nestler, EJ | 1 |
Brown, EE; Damsma, G; Fibiger, HC; Finlay, JM; Wong, JT | 1 |
Kosten, TR; Rosen, MI | 1 |
Kuribara, H; Tadokoro, S | 1 |
Kosten, TA; Kosten, TR; Morgan, C | 1 |
Bree, MP; Lukas, SE; Mello, NK; Mendelson, JH | 3 |
Goodwin, FK | 1 |
Kleber, HD; Kosten, TR; Morgan, CJ | 1 |
Kleber, HD; Kosten, TR; Morgan, C | 2 |
Bigelow, GE; Liebson, IA; Stitzer, ML; Strain, EC | 3 |
Garada, B; Holman, BL; Levin, JM; Mello, NK; Mendelson, JH; Schwartz, RB; Teoh, SK | 1 |
Kosten, TR; Stine, SM | 1 |
Carroll, ME; Comer, SD; Hunt, VR | 1 |
Carroll, ME; Comer, SD; Curtis, LK; Lac, ST | 1 |
Griffin, IJ; Jackson, HC; Nutt, DJ | 1 |
Gastfriend, DR; Kuehnle, J; Mello, NK; Mendelson, JH; Rhoades, E; Sholar, W; Teoh, SK | 1 |
Kosten, T; Oliveto, A; Schottenfeld, R; Ziedonis, D | 1 |
Janiri, L; Jones, RT; Mannelli, P; Tempesta, E | 1 |
Kosten, TR; McDougle, CJ; Pearsall, HR; Price, LH; Rosen, MI; Woods, SW | 1 |
Drieze, J; Lukas, SE; Mello, NK; Mendelson, JH | 1 |
Kosten, TR | 1 |
Drieze, JM; Kamien, JB; Lukas, SE; Mello, NK; Mendelson, JH; Sholar, JW | 1 |
Crowley, TJ; Ingersoll, NC; Mikulich, SK; Williams, EA | 1 |
Kuehnle, J; Mello, NK; Mendelson, JH; Rhoades, EM; Sintavanarong, P; Teoh, SK | 1 |
Garada, B; Hallgring, E; Holman, BL; Johnson, KA; Mello, NK; Mendelson, J; Teoh, SK | 1 |
Charuvastra, VC; Compton, PA; Ling, W; Wesson, DR | 1 |
O'Neill, WM | 1 |
Charuvastra, C; Klett, CJ; Ling, W; Wesson, DR | 1 |
Drieze, JM; Lukas, SE; Mello, NK; Mendelson, JH | 1 |
Hayase, T; Yamamoto, K; Yamamoto, Y | 2 |
Fischman, MW; Foltin, RW | 1 |
Carroll, ME; Comer, SD; Lac, ST; Wyvell, CL | 1 |
Kouri, EM; Lukas, SE; Mendelson, JH | 1 |
Edel, Y; Kintz, P; Mangin, P; Tracqui, A | 1 |
Bigelow, GE; Garner, JE; Preston, KL; Sullivan, JT; Walsh, SL | 1 |
Connerney, I; Fischman, MW; Foltin, RW; Levin, FR | 1 |
Carroll, ME; Mattox, AJ; Rodefer, JS; Thompson, SS | 1 |
Bigelow, GE; Eissenberg, T; Johnson, RE; Liebson, IA; Stitzer, ML; Strain, EC; Walsh, SL | 1 |
Kosten, TR; Oliveto, A; Pakes, JR; Schottenfeld, RS; Ziedonis, D | 1 |
Gan, Q; Knuepfer, MM | 1 |
Holtzman, SG; Kimmel, HL; Tallarida, RJ | 2 |
Mello, NK; Negus, SS | 3 |
Abiru, H; Fukui, Y; Hayase, T; Yamamoto, K; Yamamoto, Y | 1 |
Carroll, KM; Kosten, TR; O'Connor, PG; Oliveto, AH; Pakes, JA; Rounsaville, BJ; Schottenfeld, RS; Shi, JM; Triffleman, EG | 1 |
Chawarski, MC; O'Connor, PG; Pakes, J; Schottenfeld, RS | 1 |
Brandt, MR; France, CP; Galici, R | 1 |
Abiru, H; Fukui, Y; Hayase, T; Nishitani, Y; Yamamoto, K; Yamamoto, Y | 1 |
Gerrits, MA; Kuzmin, AV; van Ree, JM; Zvartau, EE | 1 |
Winger, G; Woods, JH | 1 |
Augsburger, M; Cardinal, P; Eap, C; Giroud, C; Mangin, P; Michaud, K; Sporkert, F | 1 |
George, S; Moselhy, H | 1 |
Rajabi, H; Sorge, RE; Stewart, J | 1 |
Fantoma, A; Gerra, G; Zaimovic, A | 1 |
Sorge, RE; Stewart, J | 2 |
Delzenne, C; Doublet, A; Fontaine, B; Frimat, P; Labat, L; Lhermitte, M; Marek, MC; Tellier, D; Tonneau, M | 1 |
Fagetti, R; Hanna, N; Laurenzi, P; Leonardi, C | 1 |
Placenza, FM; Rajabi, H; Stewart, J | 1 |
Choo, RE; Huestis, MA; Johnson, RE; Jones, HE; Kacinko, SL | 1 |
Accornero, VH; Bandstra, ES; Mansoor, E; Morrow, CE | 1 |
Bailly, E; Karolak, S; Levi, Y; Nefau, T; Solgadi, A | 1 |
Concheiro, M; Gray, TR; Huestis, MA; Shakleya, DM | 1 |
Greenwald, MK; Lundahl, LH; Steinmiller, CL | 1 |
McCance-Katz, EF | 1 |
Zaveri, NT | 1 |
Bermejo, AM; Botrè, F; de la Torre, X; Strano-Rossi, S | 1 |
Cami-Kobeci, G; Husbands, SM; Khroyan, TV; Polgar, WE; Toll, L; Zaveri, NT | 1 |
Christophersen, AS; Johansen, U; Oiestad, AM; Oiestad, EL | 1 |
de Castro, A; Gray, TR; Huestis, MA; Johnson, RE; Jones, HE; Shakleya, DM | 1 |
Baldassarre, C; Curcio, F; Franco, T; Topa, M | 1 |
Koob, GF; Misra, KK; Schlosburg, JE; Vendruscolo, LF; Wee, S | 1 |
Bailey, CP; Cordery, SF; Delgado-Charro, MB; Guy, RH; Husbands, SM; Ridzwan, IE; Taverner, A | 1 |
D'Apolito, K | 1 |
DInh, AT; Fiellin, DA; Fiellin, LE; Lruie, BS; McCance-Katz, EF; Moody, DE; Tetrault, JM | 1 |
Beck, O; Carlsson, S; Lindkvist, I; Olsson, R | 1 |
Goldfeld, KS; Grossman, E; Lee, JD; Rotrosen, J; Tofighi, B; Williams, AR | 1 |
Freeto, SM; LeQue, JJ; Ohouo, PY; Rosano, TG; Wood, M | 1 |
Cami-Kobeci, G; Czoty, PW; Ding, H; Husbands, SM; Kiguchi, N; Ko, MC; Nader, MA; Sukhtankar, DD | 1 |
Kim, H; Kim, J; Kim, SY; Koo, SH; Kwon, GC; Lim, J; Park, Y | 1 |
Cirone, S; Edwards, C; Folk, D; Gordon, J; Kahan, M; Kanate, D; Kelly, L; Kirlew, M; Main, F; Mamakwa, S; Parsons, P; Rea, S | 1 |
Ciccocioppo, R; de Guglielmo, G; Journigan, VB; Kallupi, M; Shen, Q; Yasuda, D; Zaveri, NT | 1 |
Chung, DY; Foster, ML; McCall, KL; Moran, MT; Nichols, SD; Piper, BJ; Shah, DT; Simpson, KJ | 1 |
Baumgartner, MR; Gastberger, S; Herdener, M; Hulka, LM; Mutschler, J; Quednow, BB; Seifritz, E; Soyka, M | 1 |
Desrosiers, C; Foster, ML; Herbert, J; McCall, KL; Moran, MT; Nichols, SD; Piper, BJ; Shah, DT; Simoyan, OM; Simpson, KJ | 1 |
Coker, JL; Doyle, R; Knight, BT; Kroska, EB; Meller, EW; Nembhard, WN; Ray-Griffith, SL; Stowe, ZN | 1 |
Barnes, M; Cippitelli, A; Toll, L; Zaveri, NT | 1 |
Dale, RC; Ford, LT; Street, C | 1 |
Daudelin, D; Guardado, R; Murphy, M; Patil, D; Wurcel, A; Zubiago, J | 1 |
Hallahan, JE; Hillhouse, TM; Husbands, SM; Jutkiewicz, EM; Koppenhaver, PO; Meurice, C; Olson, KM; Ostovar, M; Rysztak, LG; Sears, BF; Traynor, JR; West, JL | 1 |
France, CP; Gerak, LR | 1 |
Graham, DP; Hamon, SC; Hillhouse, M; Kosten, TR; Lawson, WB; Ling, W; Nielsen, DA; Nielsen, EM; Rotrosen, J; Saxon, AJ; Settles-Reaves, BD; Shmueli-Blumberg, D; Shores-Wilson, K; Trivedi, MH; Walker, R | 1 |
Antoine, D; Buresh, ME; Dunn, KE; Fingerhood, MI; Prichett, L; Sweeney, MM; Umbricht, A | 1 |
Botbyl, JD; Campbell, ANC; Luderer, HF; Maricich, YA; Nunes, EV | 1 |
Coulter, C; Garnier, M; Moore, C | 1 |
Cook, BL; Creedon, TB; Fatkin, T; Fredericksen, AK; Moore, SK; Okst, K; Oxnard, AS; Roll, D; Samawi, F; Schuman-Olivier, Z; Smith, L; Weiss, RD | 1 |
Bonny, AE; Nahata, MC; Ramey, OL; Silva Almodóvar, A | 1 |
Chander, G; Pytell, JD; Stoller, KB; Thakrar, AP; Walters, V; Weiss, RD | 1 |
Clark, B; Degenhardt, L; Farrell, M; Hickman, M; Kimber, J; Larance, B; Leppan, O; Macpherson, G; Martino-Burke, D; Nielsen, S; Zahra, E | 1 |
Case, P; Green, TC; Hughto, JMW; Moyo, P; Palacios, WR; Rapisarda, SS; Silcox, J; Stopka, TJ; Tapper, A | 1 |
Abu-Obaid, R; Achtyes, ED; Allgaier, B; Amaratunga, P; Lee-Easton, MJ; Levitas, M; Lorenz-Lemberg, B; Magura, S; Reed, P | 1 |
Balise, RR; Castillo, F; Feaster, DJ; Hu, MC; Liu, Y; Luo, SX; Nunes, EV; Rotrosen, J; Saxon, AJ; Weiss, RD | 1 |
Chander, G; Falade-Nwulia, O; Fojo, AT; Keruly, JC; Lesko, CR; Moore, RD; Pytell, JD; Snow, LN | 1 |
Comer, SD; Evans, SM; Foltin, RW; Pudiak, CM | 1 |
12 review(s) available for cocaine and buprenorphine
Article | Year |
---|---|
Human laboratory studies of buprenorphine.
Topics: Animals; Buprenorphine; Cocaine; Heroin Dependence; Humans; Opioid-Related Disorders | 1992 |
Buprenorphine for cocaine and opiate dependence.
Topics: Buprenorphine; Clinical Trials as Topic; Cocaine; Humans; Opioid-Related Disorders; Substance-Related Disorders | 1992 |
Preclinical evaluation of the effects of buprenorphine, naltrexone and desipramine on cocaine self-administration.
Topics: Animals; Buprenorphine; Cocaine; Desipramine; Humans; Macaca mulatta; Naltrexone; Self Administration | 1990 |
Buprenorphine: beyond methadone?
Topics: Acquired Immunodeficiency Syndrome; Buprenorphine; Cocaine; Humans; Methadone; Opioid-Related Disorders; Risk Factors; Substance Abuse, Intravenous; Substance-Related Disorders | 1991 |
Clinical investigations of drug effects in women.
Topics: Buprenorphine; Cocaine; Desipramine; Female; Heroin Dependence; Humans; Male; Naltrexone; Opioid-Related Disorders; Sex Factors; Substance-Related Disorders | 1986 |
Clinical and research perspectives on cocaine abuse: the pharmacotherapy of cocaine abuse.
Topics: Buprenorphine; Clinical Trials as Topic; Cocaine; Desipramine; Humans; Substance-Related Disorders | 1993 |
Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence.
Topics: Analgesics, Opioid; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Female; Humans; Male; Methadone; Substance-Related Disorders | 1995 |
Prenatal drug exposure: infant and toddler outcomes.
Topics: Buprenorphine; Child Development; Child, Preschool; Cocaine; Cocaine-Related Disorders; Female; Heroin; Humans; Infant; Infant, Newborn; Male; Methadone; Neonatal Abstinence Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Substance-Related Disorders | 2010 |
Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women.
Topics: Anti-HIV Agents; Buprenorphine; Cocaine; Drug Interactions; Female; HIV Infections; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Substance-Related Disorders | 2011 |
The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
Topics: Alcoholism; Analgesics, Opioid; Animals; Behavior, Addictive; Buprenorphine; Cocaine; Dopamine; Drug Combinations; Humans; Imidazoles; Ligands; Mice; Mice, Knockout; Morphine; Nociceptin; Nociceptin Receptor; Opioid Peptides; Psychotropic Drugs; Rats; Receptors, Opioid; Spiro Compounds; Substance-Related Disorders | 2011 |
Breastfeeding and substance abuse.
Topics: Breast Feeding; Buprenorphine; Cocaine; Contraindications; Dronabinol; Ethanol; Female; Heroin; Humans; Infant; Lactation; Methadone; Milk, Human; Substance-Related Disorders | 2013 |
Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies.
Topics: Adolescent; Adult; Analgesics, Opioid; Australia; Buprenorphine; Cocaine; Female; Humans; Male; Methadone; Opioid-Related Disorders | 2023 |
27 trial(s) available for cocaine and buprenorphine
Article | Year |
---|---|
Weighing up the pros and cons: help-seeking by drug misusers in Baltimore, USA.
Topics: Adult; Bromocriptine; Buprenorphine; Cocaine; Desipramine; Fear; Female; Fluoxetine; Humans; Male; Methadone; Middle Aged; Motivation; Opioid-Related Disorders; Patient Acceptance of Health Care; Phencyclidine Abuse; Substance Abuse Treatment Centers; Substance-Related Disorders; Urban Population | 1992 |
Buprenorphine treatment for concurrent heroin and cocaine dependence: phase I study.
Topics: Adult; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Drug Evaluation; Heroin Dependence; Humans; Male; Methadone; Substance Abuse, Intravenous | 1990 |
Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users.
Topics: Adolescent; Adult; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methadone; Opioid-Related Disorders; Patient Compliance; Psychiatric Status Rating Scales; Substance-Related Disorders; Treatment Outcome | 1994 |
Improved regional cerebral blood flow in chronic cocaine polydrug users treated with buprenorphine.
Topics: Adult; Brain; Buprenorphine; Cerebrovascular Circulation; Cocaine; Double-Blind Method; Heroin Dependence; Humans; Male; Middle Aged; Organotechnetium Compounds; Oximes; Substance-Related Disorders; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1995 |
Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance.
Topics: Adult; Buprenorphine; Cocaine; Comorbidity; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methadone; Neurologic Examination; Opioid-Related Disorders; Substance Abuse Detection; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
Comparison of buprenorphine and methadone in the treatment of opioid dependence.
Topics: Administration, Oral; Administration, Sublingual; Adult; Buprenorphine; Cocaine; Comorbidity; Double-Blind Method; Female; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Patient Compliance; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome | 1994 |
Buprenorphine effects on morphine- and cocaine-induced subjective responses by drug-dependent men.
Topics: Administration, Sublingual; Adult; Ambulatory Care; Arousal; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Heroin Dependence; Humans; Male; Morphine; Morphine Dependence; Prognosis; Substance Abuse, Intravenous; Substance-Related Disorders; Treatment Outcome | 1994 |
Effects of acute buprenorphine on responses to intranasal cocaine: a pilot study.
Topics: Adult; Affect; Arousal; Buprenorphine; Cocaine; Comorbidity; Double-Blind Method; Drug Administration Schedule; Euphoria; Female; Heroin Dependence; Humans; Male; Pilot Projects; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Acute interactions of buprenorphine with intravenous cocaine and morphine: an investigational new drug phase I safety evaluation.
Topics: Administration, Sublingual; Adult; Arousal; Blood Pressure; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Drug Interactions; Heart Rate; Heroin Dependence; Humans; Liver Function Tests; Male; Morphine; Single-Blind Method; Substance-Related Disorders | 1993 |
The cognitive and psychomotor effects of opioid drugs in cancer pain management.
Topics: Adult; Amphetamines; Analgesics, Opioid; Buprenorphine; Central Nervous System Stimulants; Chronic Disease; Cocaine; Codeine; Cognition; Dextropropoxyphene; Dopamine Uptake Inhibitors; Humans; Methylphenidate; Morphine; Neoplasms; Pain; Psychomotor Performance; Randomized Controlled Trials as Topic; Reaction Time; Thiazoles | 1994 |
A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.
Topics: Adult; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Heroin Dependence; Humans; Male; Methadone; Opioid-Related Disorders; Placebos; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome | 1996 |
Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans.
Topics: Adult; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Methadone; Opioid-Related Disorders; Self Administration; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1996 |
Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
Topics: Adolescent; Adult; Alcoholism; Buprenorphine; Cocaine; Double-Blind Method; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Abuse Detection; Substance Withdrawal Syndrome; Treatment Outcome | 1996 |
P300 assessment of opiate and cocaine users: effects of detoxification and buprenorphine treatment.
Topics: Adult; Arousal; Attention; Brain Mapping; Buprenorphine; Cerebral Cortex; Cocaine; Event-Related Potentials, P300; Heroin Dependence; Humans; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Reaction Time; Substance Withdrawal Syndrome | 1996 |
Sweat testing in opioid users with a sweat patch.
Topics: Amphetamines; Benzodiazepines; Buprenorphine; Cannabinoids; Chromatography, High Pressure Liquid; Cocaine; Codeine; Dose-Response Relationship, Drug; Gas Chromatography-Mass Spectrometry; Heroin; Heroin Dependence; Humans; Illicit Drugs; Morphine; Morphine Derivatives; Reproducibility of Results; Sweat | 1996 |
Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans.
Topics: Adult; Buprenorphine; Cocaine; Cross-Over Studies; Double-Blind Method; Drug Interactions; Humans; Hydromorphone; Liver; Male; Naltrexone; Narcotic Antagonists; Narcotics; Respiration; Substance-Related Disorders | 1996 |
A protocol to switch high-dose, methadone-maintained subjects to buprenorphine.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Buprenorphine; Clonidine; Cocaine; Drug Administration Schedule; Female; Humans; Inpatients; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Oxazepam; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Sympatholytics; Treatment Outcome | 1997 |
Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cocaine; Humans; Naloxone; Narcotic Antagonists; Narcotics; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome; Substance-Related Disorders | 1997 |
Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse.
Topics: Adult; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methadone; Opioid-Related Disorders; Substance-Related Disorders; Treatment Outcome | 1997 |
A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.
Topics: Adult; Ambulatory Care Facilities; Buprenorphine; Chi-Square Distribution; Cocaine; Drug Administration Schedule; Female; Heroin Dependence; Humans; Male; Narcotic Antagonists; Patient Dropouts; Primary Health Care; Statistics, Nonparametric; Substance-Related Disorders; Treatment Outcome; United States | 1998 |
Plasma concentrations of buprenorphine 24 to 72 hours after dosing.
Topics: Administration, Sublingual; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Double-Blind Method; Ethanol; Female; Heroin; Humans; Male; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome; Time Factors | 1999 |
Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes.
Topics: Adult; Buprenorphine; Cocaine; Double-Blind Method; Female; Humans; Infant, Newborn; Male; Maternal Behavior; Maternal-Fetal Exchange; Meconium; Methadone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Nicotine; Opiate Alkaloids; Opioid-Related Disorders; Pregnancy; Smoking | 2008 |
Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers.
Topics: Adolescent; Adult; Buprenorphine; Choice Behavior; Cocaine; Cocaine-Related Disorders; Delayed-Action Preparations; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Seeking Behavior; Female; Humans; Hydromorphone; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Reinforcement Schedule; Reward; Substance Withdrawal Syndrome | 2010 |
Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Maternal-Fetal Exchange; Meconium; Methadone; Narcotics; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Placenta; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pyrrolidines; Umbilical Cord | 2011 |
Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cocaine; Drug Therapy, Combination; Educational Status; Female; Humans; Longitudinal Studies; Male; Methadone; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Social Behavior | 2011 |
Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene.
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cocaine; Cocaine-Related Disorders; Delayed-Action Preparations; Enkephalins; Humans; Injections, Intramuscular; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Protein Precursors | 2022 |
Safety and efficacy of a digital therapeutic for substance use disorder: Secondary analysis of data from a NIDA clinical trials network study.
Topics: Buprenorphine; Central Nervous System Stimulants; Cocaine; Humans; Nitrosamines; Opiate Substitution Treatment; Opioid-Related Disorders; Substance-Related Disorders | 2022 |
94 other study(ies) available for cocaine and buprenorphine
Article | Year |
---|---|
The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Buprenorphine; Chlorides; Cocaine; Conditioning, Psychological; Lithium; Lithium Chloride; Male; Naltrexone; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1992 |
Buprenorphine attenuates the effects of cocaine on adrenocorticotropin (ACTH) secretion and mood states in man.
Topics: Adrenocorticotropic Hormone; Adult; Affect; Buprenorphine; Cocaine; Euphoria; Hemodynamics; Humans; Male; Substance-Related Disorders | 1992 |
Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone.
Topics: Animals; Buprenorphine; Cocaine; Dextroamphetamine; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Combinations; Male; Morphine; Naltrexone; Rats; Sodium Chloride | 1992 |
The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys.
Topics: Animals; Buprenorphine; Cocaine; Drug Tolerance; Female; Food; Macaca mulatta; Male; Self Administration | 1992 |
Buprenorphine's effects on self-administration of smoked cocaine base and orally delivered phencyclidine, ethanol and saccharin in rhesus monkeys.
Topics: Administration, Oral; Animals; Behavior, Animal; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Food Preferences; Injections, Intramuscular; Macaca mulatta; Male; Phencyclidine; Saccharin; Self Administration | 1992 |
Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys.
Topics: Alfentanil; Animals; Buprenorphine; Cocaine; Conditioning, Operant; Drug Interactions; Female; Infusions, Intravenous; Macaca mulatta; Male; Narcotic Antagonists; Narcotics; Reaction Time; Self Administration | 1992 |
Effects of buprenorphine on self-administration of cocaine and a nondrug reinforcer in rats.
Topics: Animals; Buprenorphine; Cocaine; Conditioning, Operant; Drinking; Eating; Injections, Intravenous; Male; Rats; Rats, Inbred Strains; Self Administration | 1992 |
The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine.
Topics: Animals; Brain; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Methadone; Mice; Mice, Inbred Strains; Morphine; Naltrexone; Receptors, Opioid; Receptors, Opioid, mu; Seizures | 1991 |
Pharmacological properties of (+)-buprenorphine and (+)-diprenorphine.
Topics: Animals; Buprenorphine; Cocaine; Diprenorphine; Guinea Pigs; In Vitro Techniques; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Self Administration | 1990 |
Antagonism of acute cocaine toxicity by buprenorphine.
Topics: Analysis of Variance; Animals; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; L-Lactate Dehydrogenase; Male; Mice; Naloxone; Naltrexone | 1991 |
Outpatient comparison of buprenorphine and methadone maintenance. II. Effects on cocaine usage, retention time in study and missed clinic visits.
Topics: Adult; Buprenorphine; Cocaine; Female; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Outpatients; Substance-Related Disorders | 1990 |
Effects of naltrexone on cocaine self-administration by rhesus monkey.
Topics: Animals; Buprenorphine; Cocaine; Eating; Macaca mulatta; Naltrexone; Self Administration | 1990 |
Buprenorphine suppresses cocaine self-administration by rhesus monkeys over 1 to 4 months of daily treatment.
Topics: Animals; Buprenorphine; Cocaine; Macaca mulatta; Self Administration | 1990 |
Buprenorphine and cocaine addiction: the need for caution.
Topics: Buprenorphine; Cocaine; Humans; Risk Factors; Substance-Related Disorders | 1991 |
Cocaine conditioned place preference is attenuated by chronic buprenorphine treatment.
Topics: Analysis of Variance; Animals; Buprenorphine; Cocaine; Conditioning, Psychological; Environment, Controlled; Male; Rats; Rats, Inbred Strains; Reinforcement, Psychology | 1991 |
Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse.
Topics: Animals; Behavior, Animal; Buprenorphine; Cocaine; Dialysis; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Male; Nucleus Accumbens; Rats; Rats, Inbred Strains; Substance-Related Disorders | 1991 |
The ambulation-increasing effect of buprenorphine in mice: comparison with the effect of morphine.
Topics: Animals; Buprenorphine; Caffeine; Cocaine; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Locomotion; Male; Methamphetamine; Mice; Morphine; Naloxone; Pilocarpine; Scopolamine | 1991 |
Depressive symptoms during buprenorphine treatment of opioid abusers.
Topics: Adult; Buprenorphine; Cocaine; Combined Modality Therapy; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Methadone; Opioid-Related Disorders; Personality Tests; Substance-Related Disorders | 1990 |
Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys.
Topics: Animals; Buprenorphine; Cocaine; Conditioning, Operant; Eating; Female; Macaca mulatta; Male; Naltrexone; Self Administration | 1990 |
From the Alcohol, Drug Abuse, and Mental Health Administration.
Topics: Animals; Antipsychotic Agents; Buprenorphine; Cocaine; Female; Heroin; Humans; Macaca mulatta; Male; Obsessive-Compulsive Disorder; Schizophrenia; Substance-Related Disorders; Trichotillomania | 1989 |
Buprenorphine suppresses cocaine self-administration in rhesus monkeys.
Topics: Animals; Appetitive Behavior; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Macaca mulatta; Self Administration; Substance-Related Disorders | 1989 |
Buprenorphine treatment of cocaine abuse.
Topics: Buprenorphine; Cocaine; Humans; Methadone; Opioid-Related Disorders; Substance Abuse Detection; Substance-Related Disorders | 1989 |
Buprenorphine suppresses cocaine self-administration by rhesus monkeys.
Topics: Animals; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Self Administration; Substance-Related Disorders | 1989 |
Treatment of cocaine abuse with buprenorphine.
Topics: Administration, Oral; Administration, Sublingual; Adult; Buprenorphine; Cocaine; Combined Modality Therapy; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Substance-Related Disorders | 1989 |
Role of opioid antagonists in treating intravenous cocaine abuse.
Topics: Adult; Buprenorphine; Cocaine; Female; Humans; Injections, Intravenous; Male; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance-Related Disorders | 1989 |
Effects of concurrent saccharin availability and buprenorphine pretreatment on demand for smoked cocaine base in rhesus monkeys.
Topics: Animals; Buprenorphine; Conditioning, Operant; Crack Cocaine; Injections, Intramuscular; Macaca mulatta; Male; Reinforcement Schedule; Saccharin; Self Administration; Substance-Related Disorders | 1994 |
Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats.
Topics: Animals; Benzimidazoles; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Drug Interactions; Male; Naltrexone; Rats; Rats, Wistar; Receptors, Opioid, mu; Reinforcement, Psychology | 1993 |
Buprenorphine-cocaine interactions in mice: effect on locomotor activity and hole-dipping behaviour.
Topics: Animals; Behavior, Animal; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Motor Activity | 1993 |
Cocaine abuse among methadone-maintained patients.
Topics: Buprenorphine; Cocaine; Comorbidity; Double-Blind Method; Humans; Methadone; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance-Related Disorders | 1993 |
Prediction in drug abuse: cocaine interactions with alcohol and buprenorphine.
Topics: Alpha Rhythm; Beta Rhythm; Brain; Buprenorphine; Cocaine; Drug Interactions; Electroencephalography; Ethanol; Euphoria; Female; Humans; Male; Mydriasis; Probability; Substance-Related Disorders | 1993 |
Naltrexone-buprenorphine interactions: effects on cocaine self-administration.
Topics: Animals; Buprenorphine; Cocaine; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Combinations; Eating; Female; Macaca mulatta; Male; Naltrexone; Reinforcement Schedule; Self Administration | 1993 |
Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys.
Topics: Animals; Buprenorphine; Cocaine; Drug Administration Schedule; Eating; Female; Macaca mulatta; Male; Self Administration | 1993 |
Buprenorphine and cocaine effects on social behavior of monkeys.
Topics: Animals; Arousal; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Grooming; Injections, Intramuscular; Macaca; Male; Motor Activity; Social Behavior; Social Environment; Stereotyped Behavior | 1993 |
Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users.
Topics: Adult; Buprenorphine; Cerebrovascular Circulation; Cocaine; Heroin; Humans; Magnetic Resonance Imaging; Male; Organotechnetium Compounds; Oximes; Substance-Related Disorders; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1993 |
Buprenorphine-induced alterations of cocaine's reinforcing effects in rhesus monkey: a dose-response analysis.
Topics: Animals; Appetitive Behavior; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Motivation; Narcotic Antagonists; Reinforcement Schedule; Self Administration | 1995 |
Protective effects of buprenorphine against amplified cocaine and ethanol lethality in mice: role of cocaethylene.
Topics: Animals; Brain Chemistry; Buprenorphine; Central Nervous System Depressants; Cocaine; Dopamine Uptake Inhibitors; Ethanol; Liver; Male; Mice; Mice, Inbred ICR; Narcotic Antagonists; Narcotics | 1996 |
Combined effects of buprenorphine and a nondrug alternative reinforcer on i.v. cocaine self-administration in rats maintained under FR schedules.
Topics: Animals; Buprenorphine; Cocaine; Conditioning, Operant; Feeding Behavior; Injections, Intravenous; Male; Narcotic Antagonists; Narcotics; Rats; Rats, Wistar; Self Administration | 1996 |
Effects of buprenorphine and an alternative nondrug reinforcer, alone and in combination on smoked cocaine self-administration in monkeys.
Topics: Animals; Buprenorphine; Cocaine; Drinking; Macaca mulatta; Male; Narcotics; Reinforcement Schedule; Reinforcement, Psychology; Saccharin; Self Administration; Sweetening Agents | 1997 |
Effects of proposed treatments for cocaine addiction on hemodynamic responsiveness to cocaine in conscious rats.
Topics: Animals; Bromocriptine; Buprenorphine; Cocaine; Desipramine; Diazepam; Dizocilpine Maleate; Hemodynamics; Male; Piperazines; Rats; Rats, Sprague-Dawley; Substance-Related Disorders | 1997 |
Synergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Buprenorphine; Catecholamines; Cocaine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Male; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Rotation; Stereotyped Behavior; Substantia Nigra | 1997 |
Theory and statistics of detecting synergism between two active drugs: cocaine and buprenorphine.
Topics: Animals; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Male; Models, Psychological; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Research Design; Rotation; Stereotyped Behavior; Substantia Nigra | 1997 |
The effects of buprenorphine on self-administration of cocaine and heroin "speedball" combinations and heroin alone by rhesus monkeys.
Topics: Animals; Buprenorphine; Cocaine; Conditioning, Psychological; Dose-Response Relationship, Drug; Female; Heroin; Macaca mulatta; Male; Self Administration; Substance-Related Disorders | 1998 |
Effects of buprenorphine and Ro 15-4513 on delayed death and brain beta-endorphin levels in rats treated with cocaine or cocaine-ethanol.
Topics: Affinity Labels; Animals; Azides; Benzodiazepines; beta-Endorphin; Brain Chemistry; Buprenorphine; Central Nervous System Depressants; Cocaine; Dopamine Uptake Inhibitors; Ethanol; Male; Narcotic Antagonists; Rats; Rats, Wistar; Stress, Physiological | 1998 |
The discriminative stimulus effects of morphine in pigeons responding under a progressive ratio schedule of food presentation.
Topics: Animals; Buprenorphine; Cocaine; Columbidae; Conditioning, Operant; Discrimination Learning; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Food; Morphine; Nalbuphine; Narcotic Antagonists; Narcotics; Reinforcement Schedule; Time Factors | 2000 |
Relationship between cocaine-induced hepatotoxic neurobehavioral & biochemical changes in mice: the antidotal effects of buprenorphine.
Topics: Adenosine Triphosphate; Alanine Transaminase; Animals; Antidotes; Behavior, Animal; Brain; Buprenorphine; Cocaine; Disease Models, Animal; Hepatic Encephalopathy; Liver; Mice; Mice, Inbred ICR; Motor Activity; Narcotic Antagonists; Narcotics | 2000 |
Influence of buprenorphine, butorphanol and nalbuphine on the initiation of intravenous cocaine self-administration in drug naive mice.
Topics: Analysis of Variance; Animals; Buprenorphine; Butorphanol; Cocaine; Dose-Response Relationship, Drug; Infusions, Intravenous; Male; Mice; Mice, Inbred DBA; Motor Activity; Nalbuphine; Narcotic Antagonists; Self Administration | 2000 |
Stress-related behavioral alterations accompanying cocaine toxicity: the effects of mixed opioid drugs.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Buprenorphine; Cocaine; Male; Mice; Mice, Inbred ICR; Motor Activity; Pentazocine; Receptors, Opioid; Stress, Physiological; Swimming | 2000 |
The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys.
Topics: Alfentanil; Analgesics, Opioid; Animals; Buprenorphine; Cocaine; Dopamine Uptake Inhibitors; Drug Tolerance; Heroin; Macaca mulatta; Male; Morphine; Nalbuphine; Reaction Time; Reinforcement, Psychology | 2001 |
Effects of indatraline and buprenorphine on self-administration of speedball combinations of cocaine and heroin by rhesus monkeys.
Topics: Animals; Buprenorphine; Cocaine; Cocaine-Related Disorders; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Female; Heroin; Heroin Dependence; Indans; Macaca mulatta; Male; Methylamines; Narcotics; Neurotransmitter Uptake Inhibitors; Self Administration | 2001 |
A fatal overdose of cocaine associated with coingestion of marijuana, buprenorphine, and fluoxetine. Body fluid and tissue distribution of cocaine and its metabolites determined by hydrophilic interaction chromatography-mass spectrometry(HILIC-MS).
Topics: Analgesics, Opioid; Biotransformation; Buprenorphine; Cannabinoids; Chromatography, Liquid; Cocaine; Drug Overdose; Fatal Outcome; Fluoxetine; Hair; HIV Seropositivity; Humans; Indicators and Reagents; Male; Marijuana Smoking; Middle Aged; Opioid-Related Disorders; Reference Standards; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Solvents; Spectrometry, Mass, Electrospray Ionization; Substance-Related Disorders | 2004 |
Cocaine-induced trichotillomania.
Topics: Adult; Buprenorphine; Cocaine; Cocaine-Related Disorders; Female; Humans; Narcotic Antagonists; Trichotillomania | 2005 |
Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement.
Topics: Analysis of Variance; Animals; Behavior, Addictive; Behavior, Animal; Buprenorphine; Chromatography, High Pressure Liquid; Cocaine; Conditioning, Operant; Dopamine; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Electroshock; Extinction, Psychological; Heroin; Male; Microdialysis; Motor Activity; Narcotics; Nucleus Accumbens; Rats; Rats, Long-Evans; Reinforcement, Psychology; Self Administration; Time Factors | 2005 |
Naltrexone and buprenorphine combination in the treatment of opioid dependence.
Topics: Adult; Affect; Buprenorphine; Cocaine; Cocaine-Related Disorders; Female; Heroin Dependence; Humans; Liver; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Psychiatric Status Rating Scales; Substance Abuse Detection; Survival Analysis | 2006 |
The effects of long-term chronic buprenorphine treatment on the locomotor and nucleus accumbens dopamine response to acute heroin and cocaine in rats.
Topics: Animals; Buprenorphine; Cocaine; Dopamine; Heroin; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Long-Evans | 2006 |
The effects of chronic buprenorphine on intake of heroin and cocaine in rats and its effects on nucleus accumbens dopamine levels during self-administration.
Topics: Animals; Behavior, Animal; Buprenorphine; Central Nervous System Stimulants; Cocaine; Conditioning, Operant; Dopamine; Heroin; Male; Microdialysis; Narcotic Antagonists; Narcotics; Nucleus Accumbens; Rats; Rats, Long-Evans; Self Administration; Time Factors | 2006 |
Effects of d-amphetamine and buprenorphine combinations on speedball (cocaine+heroin) self-administration by rhesus monkeys.
Topics: Animals; Behavior, Animal; Buprenorphine; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Feeding Behavior; Food Preferences; Heroin; Macaca mulatta; Male; Narcotics; Self Administration; Substance-Related Disorders | 2007 |
Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France).
Topics: Adolescent; Adult; Aged; Amphetamines; Analgesics, Opioid; Automobile Driving; Benzodiazepines; Buprenorphine; Cannabinoids; Central Nervous System Depressants; Cocaine; Dopamine Uptake Inhibitors; Ethanol; Female; Forensic Toxicology; France; Gas Chromatography-Mass Spectrometry; Humans; Male; Methadone; Middle Aged; Narcotics; Occupations; Prevalence; Substance Abuse Detection; Substance-Related Disorders | 2008 |
Multi-centre observational study of buprenorphine use in 32 Italian drug addiction centres.
Topics: Adult; Buprenorphine; Cocaine; Demography; Drug Administration Schedule; Female; Humans; Male; Narcotics; Observation; Opioid-Related Disorders; Psychology; Retrospective Studies; Substance Abuse Treatment Centers | 2008 |
Effects of chronic buprenorphine treatment on levels of nucleus accumbens glutamate and on the expression of cocaine-induced behavioral sensitization in rats.
Topics: Animals; Brain Mapping; Buprenorphine; Chromatography, High Pressure Liquid; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Uptake Inhibitors; Glutamic Acid; Male; Microdialysis; Motor Activity; Narcotic Antagonists; Nucleus Accumbens; Rats; Rats, Long-Evans | 2008 |
Estimation of illicit drugs consumption by wastewater analysis in Paris area (France).
Topics: Amphetamine; Buprenorphine; Chromatography, High Pressure Liquid; Cocaine; Humans; Illicit Drugs; Mass Spectrometry; N-Methyl-3,4-methylenedioxyamphetamine; Paris; Sewage | 2010 |
High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry.
Topics: Anesthetics, Local; Buprenorphine; Chromatography, Liquid; Cocaine; Female; Ganglionic Stimulants; High-Throughput Screening Assays; Humans; Limit of Detection; Methadone; Narcotics; Nicotine; Pregnancy; Saliva; Tandem Mass Spectrometry | 2010 |
Fast GC-MS method for the simultaneous screening of THC-COOH, cocaine, opiates and analogues including buprenorphine and fentanyl, and their metabolites in urine.
Topics: Buprenorphine; Cocaine; Dronabinol; Fentanyl; Gas Chromatography-Mass Spectrometry; Humans | 2011 |
The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse mode
Topics: Acute Disease; Analgesics, Opioid; Animals; Buprenorphine; CHO Cells; Cocaine; Cricetinae; Cricetulus; Disease Models, Animal; Humans; Ligands; Male; Mice; Mice, Inbred ICR; Pain; Pain Measurement; Protein Binding; Receptors, Opioid; Reward | 2011 |
Painkillers fuel growth in drug addiction. Opioid overdoses now kill more people than cocaine or heroin.
Topics: Analgesics, Opioid; Buprenorphine; Cocaine; Drug Overdose; Drug Prescriptions; Health Knowledge, Attitudes, Practice; Heroin; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain; Substance-Related Disorders; United States | 2011 |
Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Buprenorphine; Chromatography, Liquid; Cocaine; Codeine; Dronabinol; Ethylmorphine; Humans; Illicit Drugs; Methadone; Morphine; Oxycodone; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry | 2011 |
A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence.
Topics: Animals; Buprenorphine; Cocaine; Cocaine-Related Disorders; Male; Naloxone; Naltrexone; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2012 |
A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm.
Topics: Animals; Behavior, Animal; Buprenorphine; Cocaine; Conditioning, Psychological; Cues; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Reward | 2014 |
The impact of recent cocaine use on plasma levels of methadone and buprenorphine in patients with and without HIV-infection.
Topics: Adult; Anti-HIV Agents; Buprenorphine; Cocaine; Cocaine-Related Disorders; Drug Interactions; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Stereoisomerism; Time Factors | 2015 |
Application of drug testing using exhaled breath for compliance monitoring of drug addicts in treatment.
Topics: Adolescent; Adult; Aged; Amphetamines; Breath Tests; Buprenorphine; Cocaine; Drug Users; Exhalation; Female; Humans; Male; Methadone; Methamphetamine; Middle Aged; Morphine; Morphine Derivatives; Patient Compliance; Substance Abuse Detection; Young Adult | 2015 |
Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.
Topics: Analgesics, Opioid; Appointments and Schedules; Benzodiazepines; Bipolar Disorder; Buprenorphine; Cocaine; Cocaine-Related Disorders; Cohort Studies; Comorbidity; Cyclonic Storms; Depressive Disorder; Disaster Planning; Disasters; Female; Health Services Accessibility; Humans; Male; Narcotic Antagonists; New York City; Odds Ratio; Opiate Substitution Treatment; Opioid-Related Disorders; Outpatient Clinics, Hospital; Prospective Studies; Psychotic Disorders; Risk Factors; Stress Disorders, Post-Traumatic; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome | 2015 |
Definitive Drug and Metabolite Screening in Urine by UPLC-MS-MS Using a Novel Calibration Technique.
Topics: Amphetamine; Benzodiazepines; Buprenorphine; Calibration; Chromatography, High Pressure Liquid; Cocaine; Humans; Limit of Detection; N-Methyl-3,4-methylenedioxyamphetamine; Opiate Alkaloids; Oxycodone; Phencyclidine; Reproducibility of Results; Substance Abuse Detection; Tandem Mass Spectrometry | 2016 |
A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Cocaine; Drug-Related Side Effects and Adverse Reactions; Humans; Ligands; Opioid Peptides; Pain; Primates; Receptors, Opioid, mu; Respiratory Insufficiency | 2016 |
Evaluation of an Automated Reader and Color Interpretation-Based Immunoassays for Multiplexed Drug-of-Abuse Testing in Urine.
Topics: Amphetamine; Automation; Buprenorphine; China; Cocaine; Dronabinol; Gas Chromatography-Mass Spectrometry; Illicit Drugs; Immunoassay; Mass Spectrometry; Methadone; Methamphetamine; Morphine; Sensitivity and Specificity; Substance Abuse Detection | 2017 |
Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.
Topics: Adult; Benzodiazepines; Buprenorphine; Cocaine; Community Health Services; Counseling; Drug Therapy, Combination; Female; Humans; Indians, North American; Male; Medication Adherence; Middle Aged; Morphine; Naloxone; Narcotic Antagonists; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Program Evaluation; Retrospective Studies; Rural Health Services; Substance Abuse Detection; Suicide; Young Adult | 2017 |
Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption.
Topics: Animals; Behavior, Animal; Buprenorphine; Cocaine; Conditioning, Operant; Cycloheptanes; Dopamine Uptake Inhibitors; Naltrexone; Narcotic Antagonists; Nociceptin Receptor; Piperidines; Rats; Receptors, Opioid; Receptors, Opioid, mu; Self Administration | 2018 |
Descriptive, observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Cocaine; Crime; Drug Overdose; Drug Users; Female; Fentanyl; Humans; Hydrocodone; Hypnotics and Sedatives; Law Enforcement; Maine; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Sex Distribution; Young Adult | 2019 |
Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy.
Topics: Adult; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Cocaine; Cross-Sectional Studies; Delayed-Action Preparations; Female; Heroin; Humans; Male; Methadone; Morphine; Opiate Substitution Treatment; Opioid-Related Disorders; Switzerland | 2019 |
Increasing heroin, cocaine, and buprenorphine arrests reported to the Maine Diversion Alert Program.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Buprenorphine; Cocaine; Drug Users; Female; Fentanyl; Harm Reduction; Heroin; Humans; Hydrocodone; Hypnotics and Sedatives; Maine; Male; Middle Aged; Narcotic-Related Disorders; Oxycodone; Public Health; Sex Distribution; Substance-Related Disorders; Young Adult | 2019 |
Drug screening during pregnancy: Urine dip cups measure up.
Topics: Amphetamines; Analgesics, Opioid; Benzodiazepines; Buprenorphine; Cocaine; Female; Humans; Laboratories, Hospital; Methadone; Pregnancy; Pregnancy Complications; Substance Abuse Detection; Substance-Related Disorders; Urinalysis | 2019 |
Potent and selective NOP receptor activation reduces cocaine self-administration in rats by lowering hedonic set point.
Topics: Animals; Buprenorphine; Cocaine; Cocaine-Related Disorders; Cycloheptanes; Indoles; Male; Nociceptin Receptor; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Reinforcement Schedule; Self Administration | 2020 |
Are point-of-care urine drug testing devices suitable for antenatal drug screening? A study verifying the Alere® Drug Screen Test Cup for the detection of six classes of drug in a pregnant population.
Topics: Amphetamine; Benzodiazepines; Buprenorphine; Chromatography, Liquid; Cocaine; Female; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Methadone; Narcotics; Opiate Alkaloids; Point-of-Care Testing; Pregnancy; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Urinalysis | 2021 |
Increased HIV testing in people who use drugs hospitalized in the first wave of the COVID-19 pandemic.
Topics: Alcoholism; Analgesics, Opioid; Buprenorphine; Cocaine; COVID-19; Fentanyl; HIV Testing; Hospitalization; Humans; Massachusetts; Opioid-Related Disorders; Time Factors | 2021 |
The Buprenorphine Analogue BU10119 Attenuates Drug-Primed and Stress-Induced Cocaine Reinstatement in Mice.
Topics: Buprenorphine; Cocaine; Naltrexone; Receptors, Opioid, mu | 2021 |
Effects of buprenorphine/lorcaserin mixtures on preference for heroin, cocaine, or saline over food using a concurrent choice procedure in rhesus monkeys.
Topics: Animals; Benzazepines; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Heroin; Macaca mulatta; Opioid-Related Disorders; Self Administration | 2021 |
Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting.
Topics: Buprenorphine; Cocaine; Humans; Hypertension; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care; Retrospective Studies | 2022 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |
Effects of a trauma-informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof-of-concept study.
Topics: Anxiety; Buprenorphine; Cocaine; Humans; Mindfulness; Pain; Pilot Projects; Primary Health Care; Substance-Related Disorders | 2023 |
Urine Drug Test Results Among Adolescents and Young Adults in an Outpatient Office-Based Opioid Treatment Program.
Topics: Adolescent; Analgesics, Opioid; Buprenorphine; Cocaine; Humans; Methamphetamine; Opioid-Related Disorders; Outpatients; Retrospective Studies; Substance Abuse Detection; Young Adult | 2023 |
Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Cocaine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.
Topics: Analgesics, Opioid; Benzodiazepines; Buprenorphine; Crack Cocaine; Drug Overdose; Fentanyl; Heroin; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain; Pharmaceutical Preparations | 2023 |
Comparing presumptive with direct-to-definitive drug testing in oral fluid vs. urine for a U.S. national sample of individuals misusing drugs.
Topics: Buprenorphine; Cocaine; Humans; Illicit Drugs; Methadone; Saliva; Substance Abuse Detection; Tramadol | 2023 |
Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances.
Topics: Analgesics, Opioid; Buprenorphine; Cocaine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use.
Topics: Buprenorphine; Cocaine; Cocaine-Related Disorders; Female; HIV Infections; Humans; Male; Middle Aged; Opioid-Related Disorders | 2023 |
Effects of buprenorphine on candy and sweetened fluid self-administration by rhesus monkeys.
Topics: Analysis of Variance; Animals; Buprenorphine; Candy; Dose-Response Relationship, Drug; Food Preferences; Macaca mulatta; Male; Narcotics; Reinforcement Schedule; Self Administration; Sweetening Agents | 2002 |